On 16 December 2014, at 1800 [PST], a patient was prescribed to receive 8-12 mCi of
I-123 MIBG [metaiodobenzylguanidine]. The dose was delivered late to the Nuclear Medicine clinic and fell below the prescribed dosage range. The Nuclear Medicine OIC [Officer-in-Charge] changed the prescribed dosage from 8-12 mCi to 7-12 mCi, and the patient was subsequently dosed with 7.81 mCi. The procedure was successful and did not result in any medical/health impact or further need to repeat the study. [The Nuclear Medicine OIC] is currently not an authorized user (
AU) on USAF Radioactive Material Permit No. CA-07840-03/07 AFP; therefore, he does not have the authority to adjust the prescribed dosage range. It is worth noting that [the Nuclear Medicine OIC] meets all the requirements to be an
AU, and a request to add him was included with our pending permit renewal application provided to the Radioisotope Committee Secretariat (RICS) (USAF Licensee).
Location: Travis AFB, David Grant USAF Medical Center
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.